KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,780,685 | -43.6% | 16,445 | -27.6% | 0.17% | -37.1% |
| Q2 2023 | $4,927,483 | -56.9% | 22,723 | -63.9% | 0.27% | -60.5% |
| Q1 2023 | $11,443,320 | -26.7% | 63,000 | -20.7% | 0.68% | -30.1% |
| Q4 2022 | $15,615,069 | -28.2% | 79,466 | -17.8% | 0.97% | -29.7% |
| Q3 2022 | $21,752,000 | +68.6% | 96,706 | -5.2% | 1.38% | +83.8% |
| Q2 2022 | $12,900,000 | -51.6% | 101,971 | -51.5% | 0.75% | -36.4% |
| Q1 2022 | $26,637,000 | -11.4% | 210,084 | -8.4% | 1.18% | +11.0% |
| Q4 2021 | $30,059,000 | +120.2% | 229,455 | +105.6% | 1.06% | +124.1% |
| Q3 2021 | $13,653,000 | -39.8% | 111,604 | -43.9% | 0.47% | -36.3% |
| Q2 2021 | $22,695,000 | +3.7% | 199,096 | +9.4% | 0.74% | +2.3% |
| Q1 2021 | $21,879,000 | – | 181,976 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |